ImmuCell Announces Second Quarter 2016 Financial Results
Marketwire Canada - Thu Aug 11, 3:05PM CDT
PORTLAND, ME--(Marketwired - August 11, 2016) - ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced financial results for its second quarter ended June 30, 2016.
ICCC: 7.09 (-0.06)
ImmuCell to Announce Second Quarter 2016 Financial Results
Marketwire Canada - Wed Aug 03, 11:17AM CDT
Conference Call Scheduled for Thursday, August 11, 2016 at 4:30 PM ET
ICCC: 7.09 (-0.06)
ImmuCell Announces First Quarter 2016 Financial Results
Marketwired - Wed May 11, 3:16PM CDT
PORTLAND, ME--(Marketwired - May 11, 2016) - ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced financial results for its first quarter ended March 31, 2016.
ICCC: 7.09 (-0.06)
ImmuCell to Announce First Quarter 2016 Financial Results
Marketwired - Wed May 04, 12:15PM CDT
Conference Call Scheduled for Wednesday, May 11, 2016 at 4:30 PM EST
ICCC: 7.09 (-0.06)
ImmuCell Appoints Elizabeth Williams Vice President of Manufacturing Operations
Marketwired - Mon Apr 04, 4:41PM CDT
ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced the hiring of Ms. Elizabeth L. Williams as Vice President of Manufacturing Operations.
ICCC: 7.09 (-0.06)
ImmuCell Announces Full Year 2015 Financial Results
Marketwired - Wed Feb 10, 3:05PM CST
ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced financial results for its fourth quarter and year ended December 31, 2015.
ICCC: 7.09 (-0.06)
ImmuCell to Announce 2015 Financial Results
Marketwired - Thu Feb 04, 7:01AM CST
ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, will report financial results for the fourth quarter and year ended December 31, 2015 after the market closes on Wednesday, February 10, 2016. The Company has scheduled a conference call that same day Wednesday, February 10, 2016 at 4:30 PM ET to review the results.
ICCC: 7.09 (-0.06)
ImmuCell raises USD5.9m from public offering
M2 - Thu Feb 04, 3:00AM CST
Animal health company ImmuCell (NasdaqCM:ICCC) reported on Wednesday the completion of its public offering of 1,123,810 common stock at a price of USD5.25 per share.
ICCC: 7.09 (-0.06)
ImmuCell Corporation Announces Closing of $5.9 Million Public Offering of Common Stock
Marketwired - Wed Feb 03, 9:45AM CST
ImmuCell Corporation ("ImmuCell" or the "Company"
ICCC: 7.09 (-0.06)
BUYINS.NET: NVAX, DST, MSL, ICCC, HBAN, UBNK, Expected to Trade Higher After Bullish Insider Trading
M2 - Tue Feb 02, 9:04AM CST
BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Higher in the next 6 months. Novavax Inc (NASDAQ:NVAX), DST Systems Inc (NYSE
HBAN: 10.01 (+0.12), MSL: 10.16 (-0.02), NVAX: 6.84 (-0.12), ICCC: 7.09 (-0.06), UBNK: 13.99 (-0.01), DST: 121.51 (-0.39)
ImmuCell prices USD5.9m in public offering
M2 - Mon Feb 01, 3:45AM CST
Animal health company ImmuCell (NasdaqCM:ICCC) said on Friday that it has priced its public offering of 1,123,810 shares of its common stock.
ICCC: 7.09 (-0.06)
ImmuCell Corporation Announces Pricing of $5.9 Million Public Offering of Common Shares
Marketwired - Fri Jan 29, 6:30AM CST
ImmuCell Corporation ("ImmuCell" or the "Company"
ICCC: 7.09 (-0.06)
ImmuCell Corporation Announces Proposed Public Offering of Common Stock and Preliminary Full Year 2015 Results
Marketwired - Thu Jan 28, 4:53PM CST
ImmuCell Corporation ("ImmuCell" or the "Company"
ICCC: 7.09 (-0.06)